OIS XIV Speakers

Anupam Dalal, MD

By Jackie Wengrod | May 24, 2023

Dr. Anupam Dalal is a Chief Investment Officer at Acuta Capital Partners LLC. He is responsible for managing healthcare investments, with a focus on biotech.…

Read More

Andrew Gitkin

By Jackie Wengrod | December 19, 2022

Andrew joined the Firm in 2024 from Raymond James & Associates where he most recently served as a Senior Managing Director and Vice Chairman in…

Read More

Paul Bresge

By Jackie Wengrod | June 7, 2022

Paul Bresge has been a leader in the cell and gene therapy biotech space for over a decade. He is co-founder and Chief Executive Officer…

Read More
David Esposito

David Esposito

By Jackie Wengrod | June 7, 2022

David is an experienced healthcare executive who has built and scaled multiple companies that resulted in successful exits to strategic buyers. David is currently the…

Read More
James Murrey

James C. Murray

By Jackie Wengrod | May 20, 2022

James is a co-founder and partner at ExSight Ventures where he has helped lead the firm’s investments in nine transformative ophthalmic companies. In addition to…

Read More
Erin Henry

Erin Henry, PhD

By Jackie Wengrod | May 20, 2022

Erin Henry, Ph.D. is a biotech executive/clinical researcher and strategist. Her most recent role was VP, Product Strategy & Project Team Lead Development at Iveric,…

Read More
Robert Bhisitkul

Robert B. Bhisitkul, MD, PhD

By Jackie Wengrod | May 20, 2022

Dr. Bhisitkul, Professor of Ophthalmology, Alex Irvine MD Endowed Chair at the University of California San Francisco School of Medicine, has over 20 years of…

Read More
Daniela Ferrara MD PhD

Daniela Ferrara, MD, MS, PhD, FASRS

By Maureen Linnemann | September 28, 2021

Daniela Ferrara received her medical degree suma cum laude from Federal University of Rio de Janeiro, Brazil, one of the most prestigious universities in South…

Read More
Adrienne Graves

Adrienne Graves, PhD

By Jackie Wengrod | September 18, 2019

Dr. Adrienne Graves is a visual scientist by training and a global industry leader in ophthalmology. Dr. Graves was CEO of Santen Inc (2002-2010) following…

Read More

Robert Rothman, MD

By Jackie Wengrod | March 18, 2019

Dr. Robert Rothman is a board-certified ophthalmologist and Clinical Assistant Professor of Ophthalmology at the Hofstra Northwell School of Medicine and has 18 years of…

Read More

Andrew Stewart

By Jackie Wengrod | October 16, 2018

Andrew Stewart has more than 25 years of experience in the pharmaceutical industry. He joined Bausch + Lomb from AbbVie, where he most recently served…

Read More

Susan Orr, OD

By Jackie Wengrod | October 18, 2017

Notal Vision

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.